Suba Krishnan
Impact in
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Immunology top 5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
-
- Blood Coagulation and Thrombosis Mechanisms 4
- Blood groups and transfusion 2
- Genetics 7
- Hemoglobinopathies and Related Disorders 6
- Myeloproliferative Neoplasms: Diagnosis and Treatment 4
- Co-authors
- Katherine A. Hajjar (2 shared papers)Margitta Retz (1 shared paper)Sergio Bracarda (1 shared paper)Ari David Baron (1 shared paper)Matthew D. Galsky (1 shared paper)Andrea Necchi (1 shared paper)Alex Azrilevich (1 shared paper)Elizabeth R. Plimack (1 shared paper)
- Journals
- Journal of Clinical Oncology (5 papers)British Journal of Haematology (3 papers)Blood (3 papers)Clinical Chemistry (1 paper)Developmental Biology (1 paper)
- Partner nations
- United StatesItalyFrance
In The Last Decade
Suba Krishnan
21 papers receiving 2.7k citations
Suba Krishnan's Hit Papers
Peers
Comparison fields: 5 of 82
- Oncology 1.4k
- Immunology 622
- Surgery 1.2k
- Genetics 295
- Hematology 173
Countries citing papers authored by Suba Krishnan
This map shows the geographic impact of Suba Krishnan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suba Krishnan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suba Krishnan more than expected).
Fields of papers citing papers by Suba Krishnan
This network shows the impact of papers produced by Suba Krishnan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suba Krishnan. The network helps show where Suba Krishnan may publish in the future.
Co-authors
The 25 scholars most cited alongside Suba Krishnan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial Hit paper breakdown → | 2017 | 1248 |
| 2 | Efficacy and safety of pembrolizumab for the treatment of advanced biliary cancer: Results from the Hit paper breakdown → | 2020 | 346 |
| 3 | Results from an Integrated Safety Analysis of Urelumab, an Agonist Anti-CD137 Monoclonal Antibody Hit paper breakdown → | 2016 | 300 |
| 4 | 2017 | 148 | |
| 5 | 1999 | 139 | |
| 6 | 2014 | 120 | |
| 7 | 2019 | 93 | |
| 8 | 2021 | 90 | |
| 9 | 2009 | 89 | |
| 10 | 2012 | 61 | |
| 11 | 2011 | 31 | |
| 12 | 2008 | 25 | |
| 13 | 2003 | 18 | |
| 14 | 1998 | 15 | |
| 15 | 2009 | 8 | |
| 16 | 1999 | 3 | |
| 17 | 2019 | 2 | |
| 18 | 2024 | 2 | |
| 19 | 2022 | 2 | |
| 20 | 2010 | 2 |
About Suba Krishnan
Suba Krishnan is a scholar working on Hematology, Genetics, Oncology, Molecular Biology and Surgery, having authored 21 papers that have together received 2.7k indexed citations. Recurring topics across this work include Hemoglobinopathies and Related Disorders (6 papers), Cancer Immunotherapy and Biomarkers (5 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers), Blood Coagulation and Thrombosis Mechanisms (4 papers), CAR-T cell therapy research (3 papers), Blood groups and transfusion (2 papers), Protease and Inhibitor Mechanisms (2 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers). The work is most often cited by research in Oncology (1.4k citations), Immunology (622 citations), Surgery (1.2k citations), Genetics (295 citations) and Hematology (173 citations). Suba Krishnan has collaborated with scholars based in United States, Italy and France. Frequent co-authors include Katherine A. Hajjar, Margitta Retz, Sergio Bracarda, Ari David Baron, Matthew D. Galsky, Andrea Necchi, Alex Azrilevich, Elizabeth R. Plimack, Abdel Saci and Sumanta K. Pal. Their work appears in journals such as Journal of Clinical Oncology, British Journal of Haematology, Blood, Clinical Chemistry and Developmental Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.